The XXII chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XXII chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The XXII stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View XXII Detailed Price Forecast - CNN Money||View XXII Detailed Summary - Google Finance|
|View XXII Detailed Summary - Yahoo! Finance||View XXII Stock Research & Analysis - Zacks.com|
|View XXII Trends & Analysis - Trade-Ideas||View XXII Major Holders - Barrons|
|View XXII Call Transcripts - NASDAQ||View XXII Breaking News & Analysis - Seeking Alpha|
|View XXII Annual Report - CompanySpotlight.com||View XXII OTC Short Report - OTCShortReport.com|
|View XXII Fundamentals - TradeKing||View XXII SEC Filings - Bar Chart|
|View Historical Prices for XXII - The WSJ||View Performance/Total Return for XXII - Morningstar|
|View the Analyst Estimates for XXII - MarketWatch||View the Earnings History for XXII - CNBC|
|View the XXII Earnings - StockMarketWatch||View XXII Buy or Sell Recommendations - MacroAxis|
|View the XXII Bullish Patterns - American Bulls||View XXII Short Pain Metrics - ShortPainBot.com|
|View XXII Stock Mentions - StockTwits||View XXII Stock Mentions - PennyStockTweets|
|View XXII Stock Mentions - Twitter||View XXII Investment Forum News - Investor Hub|
|View XXII Stock Mentions - Yahoo! Message Board||View XXII Stock Mentions - Seeking Alpha|
|View Insider Transactions for XXII - SECform4.com||View Insider Transactions for XXII - Insider Cow|
|View XXII Major Holdings Summary - CNBC||View Insider Disclosure for XXII - OTC Markets|
|View Insider Transactions for XXII - Yahoo! Finance||View Institutional Holdings for XXII - NASDAQ|
|View XXII Stock Insight & Charts - FinViz.com||View XXII Investment Charts - StockCharts.com|
|View XXII Stock Overview & Charts - BarChart||View XXII User Generated Charts - Trading View|
Does The 22nd Century Group, Inc. (NYSEMKT:XXII) Share Price Fall With The Market?
Posted on Monday March 23, 2020
Anyone researching 22nd Century Group, Inc. (NYSEMKT:XXII) might want to consider the historical volatility of the...
22nd Century Group, Inc. Files 2019 Annual Report
Posted on Thursday March 12, 2020
22nd Century Group, Inc. (NYSE American: XXII), a leading plant biotechnology company in reduced nicotine tobacco and hemp/cannabis plant genetics research and development, yesterday filed its Annual Report on Form 10-K for the year ended December 31, 2019. A supplemental letter from Michael Zercher, President and Chief Operating Officer to shareholders is available in the Investor section of the Company’s website.
22nd Century Announces Important New Achievements with KeyGene
Posted on Wednesday March 11, 2020
WILLIAMSVILLE, N.Y. , March 11, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant biotechnology company in reduced nicotine tobacco and hemp/cannabis plant genetics research, announced today that lead scientists from 22nd Century Group and KeyGene have assembled a high quality genome sequence of two hemp/cannabis lines and established a new, proprietary hemp/cannabis bioinformatics platform. Both are believed to be among the highest quality, hemp/cannabis reference genomes in the world. “These exciting, new developments are already enabling the rapid breeding of new and proprietary hemp/cannabis plant lines with truly remarkable and potentially novel medicinal cannabinoid profiles,” said Michael Zercher, President & Chief Operating Officer of 22nd Century Group.
22nd Century Group Adds to Leadership Team
Posted on Tuesday March 10, 2020
WILLIAMSVILLE, N.Y., March 10, 2020 -- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is a leader in reduced nicotine tobacco and.